Pigmented progressive purpuric dermatosishttps://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
Pigmented progressive purpuric dermatosis zvinoreva kusakwenya kweganda mamiriro anoonekwa nekubuda kweganda repurpuric. Kukura kwechironda kunobva pa 0.3 kusvika ku 1 cm uye inowanzoonekwa mumakumbo ezasi. Iyo cortisone cream ichabatsira pakukwenya nekuvandudza kushanduka kweganda. Pigmented progressive purpuric dermatosis haikonzeri zvimwe zviratidzo kunze kwekushanduka kweganda. Zvironda zvinowanzoitika pamakumbo ezasi, asi zvinogona kuitika chero kupi pamuviri, kusanganisira maoko, maoko, torso uye kunyange mutsipa.

Kurapa ― OTC Zvinodhaka
OTC steroid mafuta
#Hydrocortisone ointment
#Hydrocortisone cream
☆ Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
  • Schamberg disease ― murume ane makore 26 okuberekwa ane chigamba cheasymptomatic pigmentation uye telangiectasia pagumbo.
    References Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260 
    NIH
    Pigmented purpuric dermatoses (PPD) iboka remamiriro eganda anoratidzwa nenzvimbo diki dzekubuda ropa pasi peganda nekuda kwekuzvimba kwecapillary. PPD inowanzotanga seyakatsvuka kusvika kune yepepuru makwapa ayo anozoita goridhe-brown sezvo hemosiderin inotorwazve.
    Pigmented purpuric dermatoses (PPD) include several skin diseases characterized by multiple petechial hemorrhage as consequence of capillaritis. PPD generally present with red to purple macules that progressively evolve to golden-brown color as the hemosiderin is reabsorbed.
     Schamberg Disease 32809367 
    NIH
    Schamberg disease ndiyo inonyanya kuzivikanwa mhando ye pigmented purpuric dermatoses (PPDs) , inova isingaperi mamiriro eganda anoonekwa nediki dzvuku kana makwapa epepuru, uye kuwedzera kweganda ruvara (zvigamba zvebrown, zvitsvuku, kana yero) . MaPPD akaiswa mumhando shanu: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura, eczematoid-like purpura of Doucas and Kapetanakis. Schamberg disease (SD) inozivikanwawo se progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressiva, Schamberg's purpura. Inonyanya kubata vanhurume uye inowanzoitika pamakumbo ezasi, asi inogonawo kuitika pazvidya, matako, hunde, kana maoko.
    Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis. Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura. It is commonly seen in males and mainly affects the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.
     Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156 
    NIH
    Ruzivo rwevarwere ve113 vane PPD rwakaongororwa, kusanganisira makumi matatu nevasere vakaitwa biopsy yeganda pachidzidzo ichi. Mhando yekiriniki yakajairika yaive chirwere cheSchamberg (60. 5%) . Mamwe mamiriro padivi pePPD aive hypertension (15. 8%) , chirwere cheshuga (10. 5%) , nevamwe. Nhoroondo dzemishonga dzakaratidza statins (13. 2%) , beta blockers (10. 5%) , nevamwe. Zvinhu zvinogona kuitika zvakabatana nePPD zvinosanganisira hutachiona hwepamusoro hwepamusoro hwekufema (5. 3%) , kumira kwenguva refu kunotungamira kune yakakwirira orthostatic pressure (2. 6%) , uye kurovedza muviri (2. 6%) . Kurapa kwaiitwa kuvarwere makumi matatu nevatanhatu (94. 7%) - oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
    Information on 113 patients with PPD was analyzed, and 38 subjects with skin biopsy were included for this study. Schamberg's disease was the most frequent clinical type (60.5%). Concomitant diseases included hypertension (15.8%), diabetes (10.5%), and others. Associated medication histories included statins (13.2%), beta blockers (10.5%), and others. Possibly associated etiologic factors were recent upper respiratory infection (5.3%), high orthostatic pressure due to prolonged standing (2.6%), and strenuous exercise (2.6%). A total of 36 patients (94.7%) were treated with one or more treatment methods, including oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.